Women’s Health Activities
Immune Checkpoint Inhibitor/Chemotherapy Combinations for Metastatic Triple-Negative Breast Cancer: Emerging Clinical Data and Managed Care Considerations
This live activity will determine the biological rationale for available and emerging treatment strategies involving immune checkpoint inhibitor (ICI)/chemotherapy combinations for the treatment of metastatic triple-negative breast cancer (mTNBC)
Economic Implications of Osteoporotic Fractures in Postmenopausal Women
This article will review several pharmacologic therapies used for the prevention and treatment of osteoporosis that pharmacists need to be familiar with to support reduction in fracture risk for their patients.
Medical Crossfire®: How Can We Optimize Multidisciplinary Management of Patients With Advanced Endometrial Cancer?
A multidisciplinary team will discuss expert guidance, with a focus on application of core concepts and the use of current and emerging treatment strategies in the care of patients with endometrial cancer.
Clinical Pharmacy Management of Metastatic Triple-Negative Breast Cancer
This activity will review the high rates of local recurrence and distance metastases in TNBC and outline the pharmacist’s important role in proactively managing patients receiving these therapies to increase adherence and minimize adverse effects.